Shares in Pavmed Inc. (NSDQ:PAVM) rose today after the medical device maker beat expectations on Wall Street with its third quarter results.
The N.Y.-based company posted a net loss of -$5.37 million, or -40¢ per share, for the 3 months ended Sept. 30, for bottom-line loss of -178.5% compared with the same period last year.
Get the full story at our sister site, Drug Delivery Business News.
The post Pavmed shares climb after Q3 EPS beat appeared first on MassDevice.